Article

Dallas NewsDallas News on 2023-05-11 13:05

Plano’s Reata Pharmaceuticals halts chronic kidney disease drug development

The decision came as the company prepares to launch sales of another drug in its pipeline for a rare neuromuscular condition.

Related news